Triatomic Management LP - THE ONCOLOGY INSTITUTE INC ownership

Quarter-by-quarter ownership
Triatomic Management LP ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$1,266,565
+154.5%
904,6890.0%0.88%
+71.6%
Q2 2023$497,579
-9.4%
904,689
+11.7%
0.51%
+38.2%
Q1 2023$549,197
-35.7%
810,145
+56.6%
0.37%
-48.6%
Q4 2022$853,840
-49.6%
517,479
+41.5%
0.72%
-26.2%
Q3 2022$1,693,000
-8.5%
365,6790.0%0.97%
-42.8%
Q2 2022$1,850,000
-39.4%
365,679
-14.6%
1.70%
-31.4%
Q1 2022$3,052,000
-21.7%
428,100
+7.0%
2.48%
+3.7%
Q4 2021$3,900,000400,0002.39%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 600,000$5,850,0004.54%
Empery Asset Management, LP 200,000$1,950,0004.07%
Parian Global Management LP 466,676$4,550,0003.65%
Triatomic Management LP 400,000$3,900,0002.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,296,107$32,137,0000.67%
Redmile Group, LLC 2,500,000$24,375,0000.55%
Alpine Global Management, LLC 384,988$3,754,0000.55%
CVI Holdings, LLC 200,000$1,950,0000.13%
Saba Capital Management, L.P. 400,000$3,732,0000.06%
FMR LLC 12,000,000$111,150,0000.01%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders